Biotinylated Cynomolgus / Rhesus macaque CD47 Protein, Fc,Avitag™ (MALS verified)

ユーザーレビュー
製品番号/仕様
価格
数量
CD7-C82F3-25ug
$360.00
CD7-C82F3-200ug
$1420.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Synonyms

    CD47, MER6, IAP, OA3

  • Source

    Biotinylated Cynomolgus / Rhesus macaque CD47 Protein, Fc,Avitag (CD7-C82F3) is expressed from human 293 cells (HEK293). It contains AA Gln 19 - Glu 141 (Accession # F7A802-1). In the region Gln 19 - Glu 141, the amino acid sequences of Cynomolgus and Rhesus macaque CD47 are identical.

    Predicted N-terminus: Gln 19

    Request for sequence
  • Molecular Characterization

    CD47 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a human IgG1 Fc tag at the C-terminus, followed by an Avi tag (Avitag™).

    The protein has a calculated MW of 42.0 kDa. The protein migrates as 57-70 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Endotoxin

    Less than 0.1 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Shipping and Storage

    This product is shipped at ambient temperature.

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • SDS-PAGE

    CD47 SDS-PAGE

    Biotinylated Cynomolgus / Rhesus macaque CD47 Protein, Fc,Avitag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    CD47 SEC-MALS

    The purity of Biotinylated Cynomolgus / Rhesus macaque CD47 Protein, Fc,Avitag (Cat. No. CD7-C82F3) is more than 85% and the molecular weight of this protein is around 105-125 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     CD47 ELISA

    Immobilized Cynomolgus SIRP alpha, Fc Tag (Cat. No. SIA-C5254) at 5 μg/mL (100 μL/well) can bind Biotinylated Cynomolgus / Rhesus macaque CD47 Protein, Fc,Avitag (Cat. No. CD7-C82F3) with a linear range of 0.2-5 ng/mL (QC tested).

    Protocol
  •  CD47 ELISA

    Immobilized Monoclonal Anti-Human CD47 Antibody, Human IgG4 at 1 μg/mL (100 μL/well) can bind Biotinylated Cynomolgus / Rhesus macaque CD47 Protein, Fc,Avitag (Cat. No. CD7-C82F3) with a linear range of 0.1-3 ng/mL (Routinely tested).

    Protocol

ユーザーレビュー
コメントを投稿

バックグランド

Leukocyte surface antigen CD47 is also known as Antigenic surface determinant protein OA3, Integrin-associated protein (IAP) and Protein MER6. CD47 contains 1 Ig-like V-type (immunoglobulin-like) domain. CD47 is very broadly distributed on normal adult tissues. CD47 has a role in both cell adhesion by acting as an adhesion receptor for THBS1 on platelets, and in the modulation of integrins and plays an important role in memory formation and synaptic plasticity in the hippocampus by similarity. CD47 is the receptor for SIRPA, binding to which prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells. CD47 Interaction with SIRPG mediates cell-cell adhesion, enhances superantigen-dependent T-cell-mediated proliferation and costimulates T-cell activation.

最新の進展

 
医薬品開発の進捗
  • 英語名:

    Cluster of differentiation 47

  • カテゴリ:

  • 市販の医薬品数:

    0 詳細

  • 治験医薬品数:

    53 詳細

  • 最新の開発ステージ:

    Phase 3 Clinical

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
  • 背景
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8